Bei Akademie registrieren
Novo-Nordisk, DK0062498333

Novo-Nordisk stock pre-market at EUR 34.65: pharmaceutical group

Published on 10/26/2026 at 07:45 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Novo Nordisk A/S says its medicines are intended for approved indications in local markets. At Lang & Schwarz the stock trades pre-market at EUR 34.65 on October 26, 2026.

Business model and address

  • Novo Nordisk A/S says its medicines are intended for approved indications in local markets.
  • The investor-relations page lists Novo Alle 1, 2880 Bagsværd, Denmark, as the company address.
  • Novo-Nordisk stock trades pre-market at EUR 34.65 at 7:43 a.m. CET at Lang & Schwarz on October 26, 2026.
Kopenhagener Hafen mit Brücken, Aquarell in Pastelltönen, nordische Atmosphäre
Novo Nordisk A/S (DK0062498333): Kopenhagener Hafenpanorama mit historischen Brücken in weichen Aquarell-Pastelltönen gemalt, Illustration mit AI erstellt.

Novo Nordisk A/S says its medicines are intended for approved indications in local markets. Novo-Nordisk stock trades pre-market at EUR 34.65 at 7:43 a.m. CET at Lang & Schwarz on October 26, 2026.

Ahead of the Xetra open

The further course from the Xetra open at 9:00 a.m. CET is shown by the continuously updated real-time quote of Novo-Nordisk stock.

Business and investor relations

The company’s investor-relations page states that its medicines are for approved indications in the applicable local country or region. The page lists Novo Nordisk A/S at Novo Alle 1, 2880 Bagsværd, Denmark, and provides the telephone number +45-4444-8888. Market context: Latest market reports.

More news and analysis on Novo-Nordisk stock

Disclaimer...
en | DK0062498333 | NOVO-NORDISK | boerse | 70412003 | bgmi